{"entity":{"type":"insider","cik":"0001587487","url":"/insider/0001587487","json_url":"/insider/0001587487.json","name":"Wigginton Jon Marc","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":20,"first":"2014-08-19","last":"2018-01-18","span_basis":"filed_date"},"name_variants":[{"name":"Wigginton Jon Marc","source":"filing","n_filings":20,"first_seen":"2014-08-19","last_seen":"2018-01-18"}],"transactions":[{"id":6289254,"accession":"0001125345-18-000007","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001125345-18-000007","line_url":"/filing/0001125345-18-000007#line-4","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Dev. & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2524.0,"shares_display":"2,524","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":50480.0,"total_display":"50,480.00","total_whole":"50,480","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-17","filed_date":"2018-01-18","scope":"insider"},{"id":6289245,"accession":"0001125345-18-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001125345-18-000007","line_url":"/filing/0001125345-18-000007#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Dev. & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2476.0,"shares_display":"2,476","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":49520.0,"total_display":"49,520.00","total_whole":"49,520","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-18","scope":"insider"},{"id":4697489,"accession":"0001125345-17-000116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001125345-17-000116","line_url":"/filing/0001125345-17-000116#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Dev. & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-21","filed_date":"2017-11-21","scope":"insider"},{"id":4184392,"accession":"0001125345-17-000099","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001125345-17-000099","line_url":"/filing/0001125345-17-000099#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Dev. & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-25","filed_date":"2017-10-26","scope":"insider"},{"id":5130306,"accession":"0001125345-17-000083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001125345-17-000083","line_url":"/filing/0001125345-17-000083#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Dev. & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-06-05","filed_date":"2017-06-06","scope":"insider"},{"id":4528897,"accession":"0001125345-17-000044","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001125345-17-000044","line_url":"/filing/0001125345-17-000044#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Dev. & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-19","filed_date":"2017-04-20","scope":"insider"},{"id":9291563,"accession":"0001552781-16-002003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001552781-16-002003","line_url":"/filing/0001552781-16-002003#line-1","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Dev. & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":29.34,"price_display":"29.34","price_state":"stated","total_value":293400.0,"total_display":"293,400.00","total_whole":"293,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-19","scope":"insider"},{"id":5354320,"accession":"0001125345-17-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001125345-17-000020","line_url":"/filing/0001125345-17-000020#line-1","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Dev. & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":29.34,"price_display":"29.34","price_state":"stated","total_value":293400.0,"total_display":"293,400.00","total_whole":"293,400","shares_owned_after":30000.0,"shares_owned_after_display":"30,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2017-02-08","scope":"insider"},{"id":2572003,"accession":"0001552781-16-001977","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001552781-16-001977","line_url":"/filing/0001552781-16-001977#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical Dev. & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical Dev. & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":29.34,"price_display":"29.34","price_state":"stated","total_value":293400.0,"total_display":"293,400.00","total_whole":"293,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-03","filed_date":"2016-10-05","scope":"insider"},{"id":2688508,"accession":"0001552781-16-001874","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001552781-16-001874","line_url":"/filing/0001552781-16-001874#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP Clinical Dev & CMO)","role_mark":"O","role_mark_label":"Officer (Sr VP Clinical Dev & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP Clinical Dev & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":30.78,"price_display":"30.78","price_state":"stated","total_value":615600.0,"total_display":"615,600.00","total_whole":"615,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-01","filed_date":"2016-08-03","scope":"insider"},{"id":2462039,"accession":"0001552781-16-001820","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001552781-16-001820","line_url":"/filing/0001552781-16-001820#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP Clinical Dev & CMO)","role_mark":"O","role_mark_label":"Officer (Sr VP Clinical Dev & CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP Clinical Dev & CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":27.22,"price_display":"27.22","price_state":"stated","total_value":136100.0,"total_display":"136,100.00","total_whole":"136,100","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-06","scope":"insider"},{"id":2153514,"accession":"0001140361-16-046988","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-046988","line_url":"/filing/0001140361-16-046988#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":29.64,"price_display":"29.64","price_state":"stated","total_value":296400.0,"total_display":"296,400.00","total_whole":"296,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-04","filed_date":"2016-01-06","scope":"insider"},{"id":9233065,"accession":"0001140361-15-037049","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-037049","line_url":"/filing/0001140361-15-037049#line-1","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":21.11,"price_display":"21.11","price_state":"stated","total_value":105550.0,"total_display":"105,550.00","total_whole":"105,550","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-01","filed_date":"2015-10-07","scope":"insider"},{"id":8608243,"accession":"0001140361-15-036689","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-036689","line_url":"/filing/0001140361-15-036689#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":21.11,"price_display":"21.11","price_state":"stated","total_value":105550.0,"total_display":"105,550.00","total_whole":"105,550","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-10-01","filed_date":"2015-10-02","scope":"insider"},{"id":9233064,"accession":"0001140361-15-037048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-037048","line_url":"/filing/0001140361-15-037048#line-1","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":37.15,"price_display":"37.15","price_state":"stated","total_value":371500.0,"total_display":"371,500.00","total_whole":"371,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-10-07","scope":"insider"},{"id":8251292,"accession":"0001140361-15-029461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-029461","line_url":"/filing/0001140361-15-029461#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":37.15,"price_display":"37.15","price_state":"stated","total_value":371500.0,"total_display":"371,500.00","total_whole":"371,500","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-03","filed_date":"2015-08-03","scope":"insider"},{"id":8924559,"accession":"0001140361-15-026266","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-026266","line_url":"/filing/0001140361-15-026266#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":37.15,"price_display":"37.15","price_state":"stated","total_value":185750.0,"total_display":"185,750.00","total_whole":"185,750","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-07-01","filed_date":"2015-07-01","scope":"insider"},{"id":8948678,"accession":"0001140361-15-014246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-014246","line_url":"/filing/0001140361-15-014246#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.86,"price_display":"30.86","price_state":"stated","total_value":154300.0,"total_display":"154,300.00","total_whole":"154,300","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-01","filed_date":"2015-04-03","scope":"insider"},{"id":8948224,"accession":"0001140361-15-003779","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-003779","line_url":"/filing/0001140361-15-003779#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr VP, Clinical)","role_mark":"O","role_mark_label":"Officer (Sr VP, Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr VP, Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":31.04,"price_display":"31.04","price_state":"stated","total_value":155200.0,"total_display":"155,200.00","total_whole":"155,200","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-02-02","filed_date":"2015-02-03","scope":"insider"},{"id":6914154,"accession":"0001209191-14-060858","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-060858","line_url":"/filing/0001209191-14-060858#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Sr V.P., Clinical)","role_mark":"O","role_mark_label":"Officer (Sr V.P., Clinical)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Sr V.P., Clinical","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.48,"price_display":"20.48","price_state":"stated","total_value":102400.0,"total_display":"102,400.00","total_whole":"102,400","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-01","filed_date":"2014-10-02","scope":"insider"},{"id":6493760,"accession":"0001209191-14-053529","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-053529","line_url":"/filing/0001209191-14-053529#line-2","is_derivative":false,"issuer_cik":"0001125345","issuer_name":"MACROGENICS INC","issuer_ticker":"MGNX","issuer_name_source":null,"issuer_url":"/issuer/0001125345","owner_cik":"0001587487","owner_name":"Wigginton Jon Marc","owner_display_name":"Wigginton Jon Marc","owner_url":"/insider/0001587487","role":"Officer (Senior VP, Clinical Dev)","role_mark":"O","role_mark_label":"Officer (Senior VP, Clinical Dev)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior VP, Clinical Dev.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.52,"price_display":"20.52","price_state":"stated","total_value":102600.0,"total_display":"102,600.00","total_whole":"102,600","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-18","filed_date":"2014-08-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001125345","name":"MACROGENICS INC","url":"/issuer/0001125345","role":"Officer (Sr VP, Clinical Dev. & CMO)","n_filings":20,"first_seen":"2014-08-19","last_seen":"2018-01-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001587487","retrieved_at":"2026-08-22T20:05:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}